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Abstract
Background: Currently, primary care for frail older people is reactive, time consuming and does not meet patients’
needs. A transition is needed towards proactive and integrated care, so that daily functioning and a good quality
of life can be preserved. To work towards these goals, two interventions were developed to enhance the care of
frail older patients in general practice: a screening and monitoring intervention using routine healthcare data (U-
PRIM) and a nurse-led multidisciplinary intervention program (U-CARE). The U-PROFIT trial was designed to evaluate
the effectiveness of these interventions. The aim of this paper is to describe the U-PROFIT trial design and to
discuss methodological issues and challenges.
Methods/Design: The effectiveness of U-PRIM and U-CARE is being tested in a three-armed, cluster randomized
trial in 58 general practices in the Netherlands, with approximately 5000 elderly individuals expected to participate.
The primary outcome is the effect on activities of daily living as measured with the Katz ADL index. Secondary
outcomes are quality of life, mortality, nursing home admission, emergency department and out-of-hours General
Practice (GP), surgery visits, and caregiver burden.
Discussion: In a large, pragmatic trial conducted in daily clinical practice with frail older patients, several
challenges and methodological issues will occur. Recruitment and retention of patients and feasibility of the
interventions are important issues. To enable broad generalizability of results, careful choices of the design and
outcome measures are required. Taking this into account, the U-PROFIT trial aims to provide robust evidence for a
structured and integrated approach to provide care for frail older people in primary care.
Trial registration: NTR2288
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Background
With an increasing number of older people in society, the
number of frail older people with complex care needs will
rise [1]. Frailty is a term often used among health care
professionals to characterize older people who have a
functional loss of resources in different domains. Frail
older people have an increased risk for adverse health
outcomes, such as mortality, morbidity and institutionali-
zation [2-5]. The increasing number of frail older people
will seriously challenge the health care system because
primary care for these patients is currently fragmented,
time consuming and reactive [6]. Because the care system
does not address their needs, many older patients and
their caregivers have a poor quality of life [7,8]. To pre-
serve functional performance and maintain independent
living in this vulnerable population, a transition is needed
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care for older people.
U n t i lt o d a y ,s c i e n t i f i ce v i d e n c eo nh o wp r i m a r yc a r e
providers can provide optimal care for frail older people
with complex care needs is inconsistent. Previous inter-
vention studies often used a selection of patients at risk
combined with an additional geriatric assessment and fol-
low-up visits [9,10]. However, evidence for these complex
interventions is not clear. Moreover, it is unclear what the
independent effectiveness of these interventions is.
One widely studied approach to select patients at risk is
panel management. Panel management involves periodic
reporting of clustered electronic medical record data from
a certain ‘patient panel’ as an overview of the most impor-
tant health parameters [11,12]. Missed patient encounters
and care gaps can then easily be identified, which enables
proactive, integrated and timesaving care. Panel manage-
ment programs have been set up for various chronic dis-
eases; however, integrated panel management approaches
for frail older patients are lacking [13].
Other solutions to prevent functional decline are com-
plex interventions, such as preventive home visiting pro-
grams with comprehensive geriatric assessments [9,14-16].
Little is known about the effectiveness of the different
interacting components of these complex interventions.
Elements that were demonstrated to be promising in dif-
ferent intervention studies are a multidisciplinary, multi-
factorial approach with tailor-made interventions and an
individual assessment for frail older people provided by a
(primary) care team with long-term follow-up [17-19].
To understand the effectiveness of these different
approaches, we developed two interventions: a screening
and monitoring intervention using routine healthcare data
with the Utrecht Periodic Risk Identification and Monitor-
ing system (U-PRIM) and a nurse-led multidisciplinary
intervention program, U-CARE. In the Utrecht Primary
care PROactive Frailty Intervention Trial (U-PROFIT), the
effectiveness of the U-PRIM intervention, alone and in
combination with U-CARE, will be assessed in comparison
to usual care. The aim is to preserve physical functioning
and improve quality of life for frail older people and their
caregivers. The trial will be conducted from October 2010
to spring 2012. The aim of this paper is to describe the
design of the U-PROFIT trial, the content of the two inter-
ventions and its methodological challenges.
Methods
Design and setting
A single-blind, three-armed, cluster-randomized con-
trolled trial with a one-year follow-up is being con-
ducted (see Figure 1). Recruitment was performed in




Selection of patients is performed by the U-PRIM system,
a software application that is installed in all participating
general practices. Exploring the electronic medical records
(EMRs) in each general practice, U-PRIM will screen for
three inclusion criteria in patients aged 60 years or older:
- Multimorbidity (defined as a frailty index score of ≥
0.20; see the ‘U-PRIM intervention’ section)
- AND/OR
- Polypharmacy (defined as the chronic use of five or
more different medications) [20]
- AND/OR
- Care gap in primary care of three or more years
(defined as not having consulted the GP in the past
three years, except for the yearly influenza vaccination).
Exclusion criteria
Terminally ill patients or patients living in an elderly
home or nursing home are excluded. Reasons for exclu-
sion are registered on the general practice level.
Procedure
At the start of the inclusion period, U-PRIM automatically
generates a list of frail patients of 60 years and older in
every participating practice. Using the U-PRIM software,
data extractions from the electronic medical records
(EMRs) in the practices are uploaded to an external server
area. Here, reports on frail patients are generated and
delivered back to the general practice. To guarantee
patient privacy, U-PRIM software encodes the personal
data by means of a third trusted party procedure, so perso-
nal data are only disclosed to the general practice
personnel.
Eligible patients are listed in the first U-PRIM report.
These patients are approached by their GP with a
patient information letter and informed consent form
for participation in the U-PROFIT trial. In addition,
patients are asked if they have an informal caregiver. If
s o ,t h ec a r e g i v e ri sa l s oi n v i t e dt op a r t i c i p a t ei nt h e
study to investigate caregiver burden.
In the practices in the control group, a similar U-
PRIM report with potentially frail patients is generated,
but this report is not visible to the GP.
Ethical considerations
The U-PROFIT trial is approved by the Institutional
Review Board of the University Medical Center Utrecht
(UMCU) with protocol ID 10-149/O and registered in
the Netherlands Trial Register: NTR2288.
Randomization and blinding
The participating general practices are randomly allo-
cated to one of the two intervention groups (A or B) or
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general practice level (see flowchart). Practices in group
A are allocated to the U-PRIM intervention, those in
group B to the U-PRIM plus U-CARE intervention and
the practices in group C formed the control group.
Within the 58 participating general practices, clusters
are created because some general practices are working
closely together at the same location. Before randomiza-
tion, clusters are stratified according to the expected
number of frail older people in the general practice.
g




U-PRIM + U-CARE 
Group c: 
Usual care 
Step 1.  
Frailty assessment 
Step 2:  
CGA at home 
Step 3:  
Tailor-made care plan 
Periodic screening with 
UPRIM followed by best 
practice care by the GP
Selection of patients with UPRIM based on 3 criteria:  
1. Multimorbidity. 2. Polypharmacy. 3. Care gap
6  and 12-month outcome assessment (T1 and T2) 
Eligible patients receive an information letter with informed consent form.  
If patients want to participate the following steps will be carried out: 
Care as usual
Baseline assessment (T0) 
Figure 1 Flowchart.
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A modified informed consent procedure is used to main-
tain a single-blind design; the so- called “consent to post-
poned information” [21,22]. With this procedure, a valid
assessment of subjective outcomes can be obtained in a
trial even if the patients cannot be blinded to the inter-
vention. Additionally, selection bias and dropout in the
control group can be reduced. In the U-PROFIT trial,
patients were not informed as to which intervention
group their general practice was allocated until the end
of the follow-up period.
Blinding of the GPs and practice nurses
Blinding the GPs and their practice nurses is not possi-
ble in this study because they are part of the
intervention.
Blinding the investigators
Because the investigators need to directly communicate
with the general practices about the study, it is not possi-
ble to blind the investigators. However, during data analy-
sis, investigators will be blinded to the data. When the
data analysis is completed, this information will be dis-
closed to the investigators.
The interventions
Two interventions are being tested in the U-PROFIT
trial: 1. Screening and Monitoring of frailty (U-PRIM)
and 2. Nurse-led multidisciplinary intervention program
(U-CARE).
Intervention 1: U-PRIM
The U-PRIM software application is an electronic moni-
toring system aiming at identification of older patients at
increased risk of frailty in routine health care data. The
software is based on periodic screening for relevant risk
factors in the EMRs of the general practice.
U-PRIM screens for three core risk factors in patients
aged 60 years or older. These are also the eligibility criteria
of the U-PROFIT trial as described earlier (multimorbid-
ity, polypharmacy and a care gap).
Multimorbidity
The frailty index concept is used as an indicator of multi-
morbidity [23]. The frailty index uses 50 so-called ‘health
deficits’: symptoms, signs, diseases, social problems and
functional impairments, all routinely encoded in the
EMR using International Classification of Primary Care
(ICPC) codes (see Additional file 1). In the choice of the
deficits, we followed previously published guidelines for
the construction of a frailty index [24].
U-PRIM assesses the number of deficits in each indivi-
dual. The frailty index score expresses the number of
deficits present as a proportion of the total number of
deficits [25]. Thus, a patent with 15 deficits has a frailty
index score of 0.30 (15/50). For this study, multimorbid-
ity based on the frailty index alone is defined as a frailty
index score of ≥ 0.20 [26].
Polypharmacy
The U-PRIM software screens the medication list for
chronic drug use, using anatomical therapeutic chemical
(ATC) codes. Chronic use is present when the medica-
tion was prescribed at least three times in the past year,
with at least one prescription in the last six months.
Polypharmacy is in this study is defined as 5 or more
different drugs in chronic use in the past year [20].
Care gap
T h ep e r i o dt h a tp a t i e n t sa r eo u to fs i g h to ft h e i rG Pi s
assessed to include possible care avoiders prone to self-
neglect, for example patients with dementia, psychiatric
conditions or alcohol abuse [27]. For this study, a “care
gap” is defined as a period of at least 3 years without GP
consultation, excluding the annual influenza vaccination.
The U-PRIM procedure
In the U-PROFIT trial, the periodic U-PRIM frailty
screening of the trial population takes place every three
months in intervention groups A and B. This results in
a U-PRIM report for each general practice with a selec-
tion of older patients at high risk of adverse health out-
comes. Patients are prioritized by means of the frailty
index score, with possibilities to prioritize according to
polypharmacy or care gap. For an example of a U-PRIM
report, see Additional file 2.
The report will be passed on to the GP in intervention
groups A and B. In group A, GPs are asked to act upon
the U-PRIM report in accordance with current available
guidelines and best practices and to carry out interven-
tions among the frail elderly patients if needed. In group
B, all patients selected by U-PRIM will receive the addi-
tional steps of the U-CARE program (see intervention
2). In every participating practice in group A and B, a
staff member is responsible for generating the reports
with the U-PRIM computer program and for distribut-
ing the report among the care providers involved. These
contact persons received protocolized, one-on-one gui-
dance with the first U-PRIM report, with an explanation
of the software application and suggestions on how to
implement the report in daily clinical practice.
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U-CARE is a nurse-led, multidisciplinary intervention
program to be used in frail patients selected by U-
PRIM. Specially trained, registered practice nurses pro-
vide structured and integrated care based on a patients’
needs approach.
U-CARE is developed by a multidisciplinary team con-
sisting of researchers and practitioners in nursing and
primary care medicine. Three experienced practice
nurses, a panel of experts and a panel of older people
are involved to validate the content.
The program consists of three steps. The first step is a
frailty assessment for patients at risk. The second step is
a comprehensive geriatric assessment (CGA) at home of
frail patients. The third step is a tailor-made care plan
with evidence-based interventions developed by the
practice nurse. Details of the development and the con-
tent of the program are described elsewhere [Bleijenberg
et al: Development of a nurse-led multidisciplinary
intervention program (U-CARE) to prevent functional
decline in frail older people in primary care,
Unpublished].
Step 1. Frailty assessment
The level of frailty in patients at risk selected by U-PRIM
will be further explored with the Groningen Frailty Indi-
cator questionnaire (GFI). The GFI is a 15-item validated
questionnaire that assesses frailty from a functional ADL/
IADL perspective on four domains: physical, cognitive,
social and psychological [28]. Scores on each item are
zero or one, and the total score ranges from 0 (not frail)
to 15 (severely frail). We chose a score of 4 or higher as
the relevant cut-off [29] for the selection of patients that
should be visited for a comprehensive geriatric assess-
ment. The GFI has shown high internal consistency and
construct validity [30]. This questionnaire will be sent to
all patients selected by U-PRIM.
The INTERMED for the Elderly (IM-E) [31] and the
Groningen Wellbeing Indicator (GWI) are additional
assessments included in U-CARE to enable a multidi-
mensional approach and to measure patients’ needs and
complexity of care among frail patients on the GFI.
Step 2. Comprehensive Geriatric Assessment at home
(CGA)
For those patients identified as being frail, a CGA at
home is conducted by a registered practice nurse. Dur-
ing this home visit, the practice nurse focuses on
patients’ health problems and needs in a structured
manner based on the outcome of the frailty assessment.
Based on the literature and their prevalence [32-34], ten
health problems in older patients with additional assess-
ments are included in the CGA (see Additional file 3).
Step 3. Tailor-made care plan
In collaboration with the GP, the practice nurse will
prepare a tailor-made care plan based on the outcome
of step 2. This tailor-made care plan consists of inter-
ventions derived from evidence-based care plans devel-
oped by the research team, practice nurses and experts.
For all ten health problems assessed in the CGA, sepa-
rate evidence-based care plans are developed. The use
of the care plan ensures uniformity among practice
nurses in tailoring and delivering interventions per
health problem. Flowcharts with suggested (nursing)
interventions per health problem are developed as a
practical tool and will help to guide the practice nurses
through a structured process of decision making.
Training program
All practice nurses will receive an extended U-CARE
t r a i n i n gp r o g r a mt h a tc o n s i s t so f5w e e k so f4h o u r so f
lessons in class and 4 hours of self-study. During this
training program, the included frailty assessments, the
content of the CGA and the evidence-based care plans
will be discussed. The U-CARE training program is set
up in collaboration with the University of Applied
Science Utrecht in the Netherlands.
One month prior to the start of the trial, all GPs and
registered practice nurses from intervention group are
participating in a training session of 4 hours in which
the content of U-CARE program is explained and dis-
cussed. Additionally, a workshop about collaboration
between GP’s and practice nurses is set up.
Outcomes and measurements
Primary outcome
The primary outcome of the U-PROFIT trial is the level
of Activities of Daily Living (ADL) as measured with the
Katz ADL index score [35]. The Katz index measures
independence of ADL on six items (bathing, dressing,
toileting, transferring, eating and the use of incontinence
materials). The score ranges from 0 (total independence)
to 6 (total dependence), and it is widely used to assess
activities of daily living [36]. Baseline ADL functioning
(T0) will be compared with ADL functioning after six
months (T1) and one year of follow-up (T2). The ques-
tionnaire will be filled in by the patient or a proxy
relative.
Secondary outcomes
Secondary outcome parameters will be measured at the
same time as the primary outcome parameter (T0-T1-
T2).
1. Quality of life will be measured with RAND-36 and
EuroQol (EQ-5D) [37,38]
2. Mortality
3. Number of nursing home admissions
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GP surgery visits
5. Caregiver burden measured with Self-Rated Burden
(VAS) and Carer-Qol [39]
Additional data collection
Routine health care data will be extracted from the
EMRs of the participating practices. Socio-demographic
data, such as age, gender, educational level, ethnicity,
marital status and living situation, will be gathered at
baseline. General practice characteristics, such as size,
percentage of older people, working experiences and
geographical location of the general practice, will also be
gathered.
Process evaluation
To understand the different components, their interac-
tion and the applicability of the U-CARE program, a
feasibility study will be conducted among doctors and
practice nurses of intervention group B. Furthermore,
interventions delivered by the practice nurse or other
health care providers will be registered to gain insight
into targeted interventions that are performed by the
practice nurses.
The U-PRIM system will be evaluated on psycho-
metric properties, prognostic value for adverse health
outcomes and in concordance with the GFI, and the sys-
tem will be refined following a user demands study.
In addition, qualitative data on patients’ satisfaction
with the U-CARE program will be qualitatively assessed.
In the end, various data will be collected to perform a
cost-effectiveness analysis, e.g., data on workload of the
GP and practice nurses and time registration.
Sample size calculation
At present, a valid estimation of the variance in the KATZ
ADL results within and between general practices cannot
be given because these data are not available for Dutch
populations. For that reason, a formal power analysis for
the cluster-randomized trial is not possible. Therefore, it is
also not feasible in this study to take into account a poten-
tial cluster effect. In line with Faber et al., [40] we assume
that any randomization effect per practice will be absent.
Furthermore, we assume that with an expected number of
at least 5000 frail older people included, relevant effects
can be found on the outcome between the clusters
because the power of a trial increases if the number of
clusters, subjects, or repeated measures within a subject
increases.
Data analysis
The data will be analyzed using SPSS version 17.0. An
‘intention to treat’ analysis will be carried out to assess
the differences between the intervention groups and the
control group regarding ADL functional status. The var-
iations in outcome between the groups will be calcu-
lated using mixed linear model analysis. Regression
analyses and (co)variation analyses will be carried out
when relevant to correct for baseline differences
between older people in the three groups. Survival ana-
lysis using a Cox regression model with Kaplan-Meier
survival curves will be used on mortality and admission
into nursing homes. As social economic status (SES),
gender, age and education are assumed to be potential
effect modifiers, subgroup analysis will be applied where
relevant. We will also take the working experience of
the participating GPs and practice nurses into account
in separate analyses.
Discussion
In this paper, we present the research design and metho-
dology of the U-PROFIT trial. This trial assesses the
effectiveness of two interventions: a proactive screening
and monitoring system and a nurse-led intervention pro-
gram. U-PROFIT is unique because of the robust and
pragmatic study design directly embedded in primary
care practice, which maximizes the generalizability of the
results. The integration of the U-PRIM proactive screen-
ing tool with the U-CARE nurse-led multidisciplinary
intervention program, once proven effective, will provide
an innovative, practical panel management approach for
frail older people that can be broadly implemented in
daily clinical practice. We met several challenges during
the design and implementation of the U-PROFIT trial.
Design
As mentioned, the two interventions are tested and
embedded in routine clinical practice. Therefore, it s
hard to create controlled experimental circumstances.
We randomized on a practice level, and some practices
may have already use screening lists or structured plans
to provide care for older people, while others have not.
In addition, in some practices, a practice nurse may
have already been part of the practice team. Because all
practices can be randomized in one of the intervention
groups or in the control group, we consider these differ-
ences in elderly care at baseline as normal variations in
clinical practice. In this way, both interventions are
compared to the broad range of routine clinical care,
enabling generalizability.
We chose a three-armed design for several reasons.
First, our baseline assumption is that the U-PRIM
screening followed by usual care and the combination of
U-PRIM and U-CARE will both give better results than
current usual care. Additionally, we hypothesize that
both interventions are synergistic and that the effect of
U-PRIM and U-CARE is more effective than the U-
PRIM intervention alone [41].
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The effectiveness of the interventions should be assessed
on outcomes that are directly relevant for patients and
their caregivers. We decided to take ADL functioning as
measured with the Katz ADL index as the primary out-
come. ADL functioning is generally reported as the
most important parameter in the lives of older people
[3]. The Katz ADL index is widely used in studies of
prognosis and effects of treatments [36,42].
Additionally, a broad array of relevant secondary out-
comes will be assessed to evaluate both interventions.
These will be measured based on a combination of self-
report, proxy report and data extraction out of routine
healthcare data.
Recruitment and compliance
Proper recruitment of older people for a clinical trial is
often considered as complex [43,44]. To improve gener-
alizability, it is important that not only healthy people
are included but also less fit older people [3]. For logisti-
cal reasons, we opted for a postal approach of eligible
patients by the participating GPs. In this approach, we
tried to find the optimal balance between extensive
information provision, which is strongly advised by the
Institutional Medical Ethic Committee, and the need for
short and simple information letters in this population.
Although patients can contact their GP or the research-
ers for extra clarification, this postal approach might
lead to some response bias with fewer cognitively
impaired or frailer patients included than with a perso-
nal approach. To limit this problem, patients who do
n o tg i v ec o n s e n ta r ea p p r o a c h e db yt e l e p h o n et w o
weeks after the information letter is sent, and home vis-
its by a research assistant are offered.
Limiting informative censoring is a second challenge
in elderly research. Informative censoring occurs when
drop-outs happen for reasons directly related to the pri-
mary outcome [45]. In U-PROFIT, this can occur
because frailer patients are more likely to die before we
can evaluate functional status at the end of follow-up.
To limit this problem and assess the extent of it, reasons
for withdrawal will be collected, and an intention-to-
treat analysis will be performed. Additionally, various
retention strategies will be applied, e.g., home visits,
interviews by phone when a postal questionnaire is diffi-
cult, small incentives, such as a U-PROFIT pen, and a
newsletter to keep patients informed about the project.
Development of the U-PRIM system
The U-PRIM system uses criteria that are known from
literature to be linked to frailty, disability and morbidity
and that have been selected by a local GP focus group
as relevant in daily clinical practice [2,46,47]. Small pilot
studies have shown that the current U-PRIM criteria
identify a significant number of patients at high risk for
frailty. However, the psychometric properties of U-
PRIM and exact cut-off values for clinically relevant risk
groups still have to be further assessed. The influence of
EMR data quality on the U-PRIM output should also be
examined [48].
While preparing for the U-PROFIT trial, major effort
was put into building the software, implementing the U-
PRIM system and testing it. However, during the trial,
technical aspects of the U-PRIM system may need to be
adjusted.
This might influence the current system of use and
acceptance during the trial. We will assist participating
centers by means of manuals, ICT assistance, and proac-
tive contact after report generation to check for any
content related questions or user feedback. With
updates on the practical implications of ongoing U-
PRIM research, we hope to keep all participating pri-
mary care providers on board. In this way, the U-PRIM
system can be further developed into an easy-to-use
frailty screening instrument that contributes to efficient
and proactive panel management care. Requiring only
sound EMR registration habits and periodic data upload,
the U-PRIM system is an ideal candidate for efficient
risk stratification of older people in primary care.
Feasibility and adherence
The U-CARE program is a complex, multifactorial inter-
vention with multiple components. In the trial, U-CARE
will be provided by over 20 practice nurses and over 100
doctors, and optimal implementation is vital. By means
of an extended training program and ongoing education
during the trial, we aim for a uniform baseline level of
knowledge and skills among the practice nurses. How-
ever, motivation for proactive care provision and profes-
sional experience with older patients can be different
within the group of GPs and practice nurses. These dif-
ferences reflect daily clinical practice, so general conclu-
sions about the effectiveness can be drawn. However, the
effectiveness may differ in relation to characteristics of
health care professionals. For that reason, we will per-
form subgroup analyses.
Finally, this program is based on a proactive care
approach. Some patients will appreciate the active inter-
ference of care providers, but other patients might not
and consider it as patronizing. Possible benefits of a
proactive outreach should therefore clearly outweigh the
unwanted burden it may put on others.
Strengths
Despite many challenges, we think that U-PROFIT
offers many opportunities. First, the design of a three-
armed, cluster randomized trial enables us to investigate
the effectiveness of both interventions separately as well
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mends that trials on frailty should target persons aged
70 and older, because in younger age groups, frailty pre-
valence is thought to be too low [3]. However, during
the development of U-PROFIT, general practitioners
suggested to lower the age threshold for inclusion to 60.
A substantial part of the ageing population in the prac-
tices consists of first generation immigrants of non-
Dutch origin. In these elderly individuals, who often
came to Holland for physical labor, frailty is reported to
appear at a relatively young age [7]. With the inclusion
of patients aged 60 years and older in our study, we
include the group most relevant in current clinical
practice.
T h ef r a i l t yi n d e xs c o r ei sd e m o n s t r a t e dt ob eav a l u -
able indicator of the ‘frailty state’ of an individual. Frailty
indices constructed differently, with different deficit
content and considering different numbers of deficits,
yield closely related results [25]. In this trial, we aim to
demonstrate that the frailty index can be used for struc-
tured risk assessment in primary care practice, using
routine care data.
For optimal implementation of the U-CARE interven-
tion, we will maintain a training and supervision process
of the practice nurses during the trial. In monthly meet-
ings, special attention will be paid to collaboration
between nurses and GPs to achieve optimal functioning
of this important team. In addition, lectures and educa-
tion about geriatric health problems will be performed.
During regular project meetings, research updates will
be provided to inform nurses and GPs.
While the intervention in non-pharmacological inter-
vention studies is often poorly described, the interven-
tions in the U-PROFIT trial consist of well-defined and
thoroughly designed components. This will safeguard
the reproducibility of the intervention program once the
effectiveness is established.
Although various challenges have to be addressed, the
U-PROFIT trial offers excellent opportunities for a valid
scientific evaluation of a structured and integrated
approach to improve physical functioning in frail older
people in primary care. Once proven effective, it can be
broadly implemented in daily clinical practice.
Trial status
Data collection started in October 2010 and will end in
March 2011. The results of this study will be expected
in spring 2013.
Additional material
Additional file 1: ICPC encoded frailty index deficits.
Additional file 2: Lay-out of UPRIM report.
Additional file 3: Overview of health problems, assessments and
summary of interventions.
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